Corcept Therapeutics Incorporated · NASDAQ:CORT

Wilson James N sold 10,000 Corcept Therapeutics Incorporated shares (Form 4)

Traded Aug 14, 2026 · Filed Aug 18, 2026

On Aug 14, 2026, Wilson James N (Director) sold 10,000 Corcept Therapeutics Incorporated shares at an average US$111.42 for US$1.11M under a trading plan, leaving 1,074,543 shares. Filed Aug 18, 2026 (Form 4).

Sold
10,000 shares
Price
US$111.42 average (US$110.49 to US$112.64)
Value
US$1.11M
Holding after
1,074,543 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 14, 2026Common StockSale3,053US$110.491,081,490Indirect
Aug 14, 2026Common StockSale4,668US$111.441,076,822Indirect
Aug 14, 2026Common StockSale2,279US$112.641,074,543Indirect

Source

View original at SEC

Related